Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): A randomised, double-blind, placebo-controlled, multicentre phase 3 trial
De aanwezigheid van koolhydraten en eiwitten in de maaltijd kan de opname van L-Carnitine verbeteren en de effectiviteit ervan optimaliseren bij het transport van vetzuren
Although the mechanisms of action for BPC 157 are not yet fully understood, both in the currently reviewed and other surrounding literature, some light has been shed on a few potential systems involving nitric oxide (NO) (Sikiric et al
Stable gastric pentadecapeptide BPC 157, Robert's stomach cytoprotection/adaptive cytoprotection/organoprotection, and Selye's stress coping response
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,783 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
Foundayo (orforglipron) Foundayo offers flexibility as it can be taken without restrictions on time or food, providing an average weight loss of 12.4% in clinical studies
